The beneficial effects of G2-SUISO against hepatic steatosis in NASH elderly rats may be exerted through the inhibition of lipogenesis pathways by reducing SREBP-1c, ACC and FAS expression, thereby causing a reduction in the hepatic fat accumulation and a significant decrease in TC levels in serum. The gene discussed is SREBF1; the disease is Hepatic steatosis.